194 related articles for article (PubMed ID: 35721506)
41. Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation.
Parthasarathy G; Chen J; Chen X; Chia N; O'Connor HM; Wolf PG; Gaskins HR; Bharucha AE
Gastroenterology; 2016 Feb; 150(2):367-79.e1. PubMed ID: 26460205
[TBL] [Abstract][Full Text] [Related]
42. Tissue vs. Fecal-Derived Bacterial Dysbiosis in Precancerous Colorectal Lesions: A Systematic Review.
Valciukiene J; Strupas K; Poskus T
Cancers (Basel); 2023 Mar; 15(5):. PubMed ID: 36900392
[TBL] [Abstract][Full Text] [Related]
43. Amish (Rural) vs. non-Amish (Urban) Infant Fecal Microbiotas Are Highly Diverse and Their Transplantation Lead to Differences in Mucosal Immune Maturation in a Humanized Germfree Piglet Model.
Dhakal S; Wang L; Antony L; Rank J; Bernardo P; Ghimire S; Bondra K; Siems C; Lakshmanappa YS; Renu S; Hogshead B; Krakowka S; Kauffman M; Scaria J; LeJeune JT; Yu Z; Renukaradhya GJ
Front Immunol; 2019; 10():1509. PubMed ID: 31379808
[TBL] [Abstract][Full Text] [Related]
44. The oral microbiota in colorectal cancer is distinctive and predictive.
Flemer B; Warren RD; Barrett MP; Cisek K; Das A; Jeffery IB; Hurley E; O'Riordain M; Shanahan F; O'Toole PW
Gut; 2018 Aug; 67(8):1454-1463. PubMed ID: 28988196
[TBL] [Abstract][Full Text] [Related]
45. Gut Mucosal Microbiome Signatures of Colorectal Cancer Differ According to BMI Status.
Shaw S; Berry S; Thomson J; Murray GI; El-Omar E; Hold GL
Front Med (Lausanne); 2021; 8():800566. PubMed ID: 35211486
[TBL] [Abstract][Full Text] [Related]
46. Probiotics modify human intestinal mucosa-associated microbiota in patients with colorectal cancer.
Gao Z; Guo B; Gao R; Zhu Q; Wu W; Qin H
Mol Med Rep; 2015 Oct; 12(4):6119-27. PubMed ID: 26238090
[TBL] [Abstract][Full Text] [Related]
47. Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer.
Osman MA; Neoh HM; Ab Mutalib NS; Chin SF; Mazlan L; Raja Ali RA; Zakaria AD; Ngiu CS; Ang MY; Jamal R
Sci Rep; 2021 Feb; 11(1):2925. PubMed ID: 33536501
[TBL] [Abstract][Full Text] [Related]
48. The Comparison of Fecal Microbiota in Left-Side and Right-Side Human Colorectal Cancer.
Miyake T; Mori H; Yasukawa D; Hexun Z; Maehira H; Ueki T; Kojima M; Kaida S; Iida H; Shimizu T; Ohno M; Andoh A; Tani M
Eur Surg Res; 2021; 62(4):248-254. PubMed ID: 34198297
[TBL] [Abstract][Full Text] [Related]
49. Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota.
Chen H; Zhang F; Li R; Liu Y; Wang X; Zhang X; Xu C; Li Y; Guo Y; Yao Q
Biomed Pharmacother; 2020 Apr; 124():109829. PubMed ID: 31958765
[TBL] [Abstract][Full Text] [Related]
50. Colorectal Cancer-Associated Microbiome Patterns and Signatures.
Zhao L; Cho WC; Nicolls MR
Front Genet; 2021; 12():787176. PubMed ID: 35003221
[TBL] [Abstract][Full Text] [Related]
51. Metagenomics analysis reveals universal signatures of the intestinal microbiota in colorectal cancer, regardless of regional differences.
Berbert L; Santos A; Magro DO; Guadagnini D; Assalin HB; Lourenço LH; Martinez CAR; Saad MJA; Coy CSR
Braz J Med Biol Res; 2022; 55():e11832. PubMed ID: 35293551
[TBL] [Abstract][Full Text] [Related]
52. Differential clustering of fecal and mucosa-associated microbiota in 'healthy' individuals.
Carstens A; Roos A; Andreasson A; Magnuson A; Agréus L; Halfvarson J; Engstrand L
J Dig Dis; 2018 Dec; 19(12):745-752. PubMed ID: 30467977
[TBL] [Abstract][Full Text] [Related]
53. Alterations in the oral and gut microbiome of colorectal cancer patients and association with host clinical factors.
Wang Y; Zhang Y; Qian Y; Xie YH; Jiang SS; Kang ZR; Chen YX; Chen ZF; Fang JY
Int J Cancer; 2021 Apr; ():. PubMed ID: 33844851
[TBL] [Abstract][Full Text] [Related]
54. Alterations of the Gut Microbiome and Fecal Metabolome in Colorectal Cancer: Implication of Intestinal Metabolism for Tumorigenesis.
Du X; Li Q; Tang Z; Yan L; Zhang L; Zheng Q; Zeng X; Chen G; Yue H; Li J; Zhao M; Han YP; Fu X
Front Physiol; 2022; 13():854545. PubMed ID: 35600308
[No Abstract] [Full Text] [Related]
55. Dysbiosis of skin microbiome and gut microbiome in melanoma progression.
Mekadim C; Skalnikova HK; Cizkova J; Cizkova V; Palanova A; Horak V; Mrazek J
BMC Microbiol; 2022 Feb; 22(1):63. PubMed ID: 35216552
[TBL] [Abstract][Full Text] [Related]
56. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
[TBL] [Abstract][Full Text] [Related]
57. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
[TBL] [Abstract][Full Text] [Related]
58. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
[TBL] [Abstract][Full Text] [Related]
59. Biodiversity and richness shifts of mucosa-associated gut microbiota with progression of colorectal cancer.
Pan HW; Du LT; Li W; Yang YM; Zhang Y; Wang CX
Res Microbiol; 2020; 171(3-4):107-114. PubMed ID: 31982498
[TBL] [Abstract][Full Text] [Related]
60. 16S rRNA of Mucosal Colon Microbiome and CCL2 Circulating Levels Are Potential Biomarkers in Colorectal Cancer.
Nardelli C; Granata I; Nunziato M; Setaro M; Carbone F; Zulli C; Pilone V; Capoluongo ED; De Palma GD; Corcione F; Matarese G; Salvatore F; Sacchetti L
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
